Real-world diagnostic performance of blood-based biomarkers for Alzheimer’s disease: robust performance except after stroke and high charlson comorbidity index
Overall, patient factors had limited impact on biomarkers, but caution is needed for patients with stroke or high CCI.
Authors
- Calvin Trieu (ORCID: https://orcid.org/0000-0001-6266-2198)
- Mariam Gouda (ORCID: https://orcid.org/0009-0003-4187-3131)
- David John Wilson (ORCID: https://orcid.org/0000-0002-7034-5421)
- Thomas Claessen
- Inge M.W. Verberk
- Sinthujah Vigneswaran
- Elsmarieke van de Giessen
- Rebecca Z. Rousset
- Afina W. Lemstra
- Yolande A.L. Pijnenburg
- Charlotte E. Teunissen
- Argonde C. van Harten
Institutions
- Amsterdam Neuroscience (NL)
- IDEX Corporation (United States) (US)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1186/s13195-026-01979-9
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amsterdam Neuroscience